Seroprevalence of Fascioliasis in the Eastern Region of Turkey: an Eight-year Investigation

Overview

Journal Turk J Gastroenterol

Publisher Aves

Specialty Gastroenterology

Date 2020 Dec 28

PMID 33361036

Citations 3

Authors

Yunus Emre Beyhan

Hasan Yilmaz

Affiliations

Soon will be listed here.

Abstract

Background/aims: Fascioliasis is a zoonotic disease and one of the most neglected infectious diseases in humans. Its prevalence has been increasing significantly during the last decades. This study aimed to investigate the prevalence of fascioliasis using direct microscopy and indirect hemagglutination (IHA) technique in a region in Eastern Anatolia of Turkey.

Material And Methods: This study was conducted on the serum samples obtained from 817 patients (372 male and 445 female) between 2011 and 2018, who were suspected to have fascioliasis. IHA was used to investigate anti-Fasciola hepatica antibodies in the serum samples. Stool specimens were obtained from the seropositive patients and were examined with the native-Lugol method to identify the parasites.

Results: It was determined that 5.5% (45/817) of all the patients were F. hepatica seropositive and 6.4% (52/817) were borderline positive. Positivity was 5.7% (21/372) among males and 5.4% (24/445) among females, and the difference in the infection rates between these groups was not significant (p=0.913). The highest number of patients who applied to the clinic was in the "45 and over" age group (317 patients); 270 patients were in the 25-44 age group. A maximum positivity of 10.3% was observed in the 7-14 age group.

Conclusion: Previously, fascioliasis was considered a rare infection in humans; however, it has emerged as an important public health problem in the world. Considering fascioliasis in patients with clinical symptoms, not only with direct observation but also using serological methods, would be effective in early diagnosis and treatment of the disease.

Citing Articles

Significance of climate change in the emergence of human fascioliasis in Upper Egypt.

Zanaty N, Ibrahim N, Karam-Allah Ramadan H, Ahmad A, Saad-Hussein A Trop Dis Travel Med Vaccines. 2024; 10(1):24.

PMID: 39616391 PMC: 11608467. DOI: 10.1186/s40794-024-00234-z.

Challenges in Diagnosis and Treatment of Infection.

Pinarlik F, Keske S, Rozanes I, Ergonul O Infect Dis Clin Microbiol. 2024; 5(1):49-52.

PMID: 38633907 PMC: 10986698. DOI: 10.36519/idcm.2023.197.

The global prevalence of human fascioliasis: a systematic review and meta-analysis.

Rosas-Hostos Infantes L, Paredes Yataco G, Ortiz-Martinez Y, Mayer T, Terashima A, Franco-Paredes C Ther Adv Infect Dis. 2023; 10:20499361231185413.

PMID: 37434654 PMC: 10331341. DOI: 10.1177/20499361231185413.

References

Karahocagil M, Akdeniz H, Sunnetcioglu M, Cicek M, Mete R, Akman N . A familial outbreak of fascioliasis in Eastern Anatolia: a report with review of literature. Acta Trop. 2008; 118(3):177-83. DOI: 10.1016/j.actatropica.2008.08.013. View

Bacq Y, Besnier J, Duong T, Pavie G, Metman E, Choutet P . Successful treatment of acute fascioliasis with bithionol. Hepatology. 1991; 14(6):1066-9. View

Ozturhan H, Emekdas G, Sezgin O, Korkmaz M, Altintas E . Seroepidemiology of Fasciola Hepatica in Mersin province and surrounding towns and the role of family history of the Fascioliasis in the transmission of the parasite. Turk J Gastroenterol. 2009; 20(3):198-203. DOI: 10.4318/tjg.2009.0007. View

Farag H, Barakat R, Ragab M, Omar E . A focus of human fascioliasis in the Nile Delta, Egypt. J Trop Med Hyg. 1979; 82(9-10):188-90. View

Bjorland J, Bryan R, Strauss W, Hillyer G, McAuley J . An outbreak of acute fascioliasis among Aymara Indians in the Bolivian Altiplano. Clin Infect Dis. 1995; 21(5):1228-33. DOI: 10.1093/clinids/21.5.1228. View

Kaya S, Demirci M, Demirel R, Aridogan B, Ozturk M, Korkmaz M . Seroprevalence of fasciolosis and the difference of fasciolosis between rural area and city center in Isparta, Turkey. Saudi Med J. 2006; 27(8):1152-6. View

Stork M, Venables G, Jennings S, Beesley J, Bendezu P, Capron A . An investigation of endemic fascioliasis in Peruvian village children. J Trop Med Hyg. 1973; 76(9):231-5 passim. View

Apt W, Aguilera X, Vega F, Alcaino H, Zulantay I, Apt P . [Prevalence of fascioliasis in humans, horses, pigs, and wild rabbits in 3 Chilean provinces]. Bol Oficina Sanit Panam. 1993; 115(5):405-14. View

Pulpeiro J, Armesto V, Varela J, Corredoira J . Fascioliasis: findings in 15 patients. Br J Radiol. 1991; 64(765):798-801. DOI: 10.1259/0007-1285-64-765-798. View

10.

Knobloch J, Delgado E, Alvarez A, Reymann U, Bialek R . Human fascioliasis in Cajamarca/Peru. I. Diagnostic methods and treatment with praziquantel. Trop Med Parasitol. 1985; 36(2):88-90. View

11.

Demirci M, Yildirim M, Cicioglu Aridogan B, Baysal V, Korkmaz M . Tissue parasites in patients with chronic urticaria. J Dermatol. 2003; 30(11):777-81. DOI: 10.1111/j.1346-8138.2003.tb00477.x. View

12.

Kaplan M, Kuk S, Kalkan A, Demirdag K, Ozdarendeli A . [Fasciola hepatica seroprevalence in the Elaziğ region]. Mikrobiyol Bul. 2003; 36(3-4):337-42. View

13.

Esteban J, Flores A, Angles R, Strauss W, Aguirre C, Mas-Coma S . A population-based coprological study of human fascioliasis in a hyperendemic area of the Bolivian Altiplano. Trop Med Int Health. 1997; 2(7):695-9. DOI: 10.1046/j.1365-3156.1997.d01-356.x. View

14.

Mas-Coma S, Bargues M, Valero M . Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol. 2005; 35(11-12):1255-78. DOI: 10.1016/j.ijpara.2005.07.010. View

15.

COrdova M, REATEGUI L, Espinoza J . Immunodiagnosis of human fascioliasis with Fasciola hepatica cysteine proteinases. Trans R Soc Trop Med Hyg. 1999; 93(1):54-7. DOI: 10.1016/s0035-9203(99)90178-5. View

16.

Mas-Coma S . Epidemiology of fascioliasis in human endemic areas. J Helminthol. 2005; 79(3):207-16. DOI: 10.1079/joh2005296. View

17.

Tas Cengiz Z, Yilmaz H, Dulger A, Akdeniz H, Karahocagil M, Cicek M . Seroprevalence of human fascioliasis in Van province, Turkey. Turk J Gastroenterol. 2015; 26(3):259-62. DOI: 10.5152/tjg.2015.8001. View

18.

Turhan O, Korkmaz M, Saba R, Kabaaaliogu A, Inan D, Mamikoglu L . Seroepidemiology of fascioliasis in the Antalya region and uselessness of eosinophil count as a surrogate marker and portable ultrasonography for epidemiological surveillance. Infez Med. 2007; 14(4):208-12. View

19.

Johnston S, Ballard M, Beach M, Causer L, Wilkins P . Evaluation of three commercial assays for detection of Giardia and Cryptosporidium organisms in fecal specimens. J Clin Microbiol. 2003; 41(2):623-6. PMC: 149727. DOI: 10.1128/JCM.41.2.623-626.2003. View